Raffles Medical Group

Fund raises Raffles Medical stake; Geo Energy lead ID and shareholder lower stakes - THE EDGE SINGAPORE

Insider moves

Fund raises Raffles Medical stake; Geo Energy lead ID and shareholder lower stakes

Raffles Medical has been steadily buying back its own shares, while chairman Dr Loo Choon Yong bought as well
Raffles Medical chairman Loo raises stake; ST Engineering buys back shares - THE EDGE SINGAPORE

Insider moves

Raffles Medical chairman Loo raises stake; ST Engineering buys back shares

Current FY2022 is a "transition year" for Raffles Medical
Raffles Medical a 'buy' even though growth set to normalise once pandemic abates - THE EDGE SINGAPORE

Broker's Calls

Raffles Medical a 'buy' even though growth set to normalise once pandemic abates

Ong, Jaiswal, and DBS’ Tan have posted “buy” calls on Raffles Medical at target prices of $1.50, $1.55 and $1.63 respectively.
Raffles Medical posts 27.7% increase in FY2021 earnings to $84.2 million; declares final dividend of 2.8 cents  - THE EDGE SINGAPORE

Results

Raffles Medical posts 27.7% increase in FY2021 earnings to $84.2 million; declares final dividend of 2.8 cents

The group’s net asset value per share came in at 45.75 cents on Dec 31 2021, from 40.13 cents seen in the year before.
'Buy' Raffles Medical Group on current share price weakness: RHB - THE EDGE SINGAPORE

Broker's Calls

'Buy' Raffles Medical Group on current share price weakness: RHB

RHB has a target price of $1.65 for Raffles Medical Group.
1007 Brokers Digest - THE EDGE SINGAPORE

Broker's Calls

1007 Brokers Digest

Take a look at these stocks for this week, including Sea, Capitaland Investment, and Raffles Medical Group.
'Buy' Raffles Medical and Q&M Dental as reopening begins: Maybank Kim Eng - THE EDGE SINGAPORE

Broker's Calls

'Buy' Raffles Medical and Q&M Dental as reopening begins: Maybank Kim Eng

Reopening is good for healthcare plays, says Maybank Kim Eng Research analysts Lai Gene Lih and Eric Ong.

New director at Raffles Medical and substantial shareholder at Accrelist raise respective stakes

For the 1HFY2021 ended June 30, the company reported earnings more than doubled to nearly $39.5 million
×